144 related articles for article (PubMed ID: 9624470)
1. Effect of metronidazole resistance on bacterial eradication of Helicobacter pylori in infected children.
Raymond J; Kalach N; Bergeret M; Benhamou PH; Barbet JP; Gendrel D; Dupont C
Antimicrob Agents Chemother; 1998 Jun; 42(6):1334-5. PubMed ID: 9624470
[TBL] [Abstract][Full Text] [Related]
2. Spiramycin as an alternative to amoxicillin treatment associated with lansoprazole/metronidazole for Helicobacter pylori infection in children.
Kalach N; Raymond J; Benhamou PH; Bergeret M; Senouci L; Gendrel D; Dupont C
Eur J Pediatr; 1998 Jul; 157(7):607-8. PubMed ID: 9686829
[No Abstract] [Full Text] [Related]
3. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
Kalach N; Benhamou PH; Bergeret M; Gottrand F; Husson MO; Barbier C; Dupont C; Raymond J
Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
[TBL] [Abstract][Full Text] [Related]
4. Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection.
Chuang CH; Sheu BS; Huang AH; Yang HB; Wu JJ
Helicobacter; 2002 Oct; 7(5):310-6. PubMed ID: 12390211
[TBL] [Abstract][Full Text] [Related]
5. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
[TBL] [Abstract][Full Text] [Related]
6. Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: a short report.
Schwartz H; Krause R; Siepman N; Haber M; Weissfeld A; Kidd S; Rose P; Sahba B
Helicobacter; 1996 Dec; 1(4):251-5. PubMed ID: 9398876
[TBL] [Abstract][Full Text] [Related]
7. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
Wong BC; Xiao SD; Hu FL; Qian SC; Huang NX; Li YY; Hu PJ; Daldiyono ; Manan C; Lesmana L; Carpio RE; Perez JY; Fock KM; Kachintorn U; Phornphutkul K; Kullavanijaya P; Ho J; Lam SK
Aliment Pharmacol Ther; 2000 Feb; 14(2):217-24. PubMed ID: 10651663
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
[TBL] [Abstract][Full Text] [Related]
9. A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection.
Shashidhar H; Peters J; Lin CH; Rabah R; Thomas R; Tolia V
J Pediatr Gastroenterol Nutr; 2000 Mar; 30(3):276-82. PubMed ID: 10749411
[TBL] [Abstract][Full Text] [Related]
10. Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy.
Huang AH; Sheu BS; Yang HB; Huang CC; Wu JJ; Lin XZ
J Formos Med Assoc; 2000 Sep; 99(9):704-9. PubMed ID: 11000734
[TBL] [Abstract][Full Text] [Related]
11. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.
Misiewicz JJ; Harris AW; Bardhan KD; Levi S; O'Morain C; Cooper BT; Kerr GD; Dixon MF; Langworthy H; Piper D
Gut; 1997 Dec; 41(6):735-9. PubMed ID: 9462204
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Harford W; Lanza F; Arora A; Graham D; Haber M; Weissfeld A; Rose P; Siepman N
Helicobacter; 1996 Dec; 1(4):243-50. PubMed ID: 9398875
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
Treiber G; Wittig J; Ammon S; Walker S; van Doorn LJ; Klotz U
Arch Intern Med; 2002 Jan; 162(2):153-60. PubMed ID: 11802748
[TBL] [Abstract][Full Text] [Related]
14. Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.
Sancar M; Izzettin FV; Apikoglu-Rabus S; Besisik F; Tozun N; Dulger G
Pharm World Sci; 2006 Aug; 28(4):207-14. PubMed ID: 17066247
[TBL] [Abstract][Full Text] [Related]
15. Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies.
Poon SK; Chang CS; Su J; Lai CH; Yang CC; Chen GH; Wang WC
Aliment Pharmacol Ther; 2002 Feb; 16(2):291-6. PubMed ID: 11860412
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
Ellenrieder V; Boeck W; Richter C; Marre R; Adler G; Glasbrenner B
Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
[TBL] [Abstract][Full Text] [Related]
17. Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori.
Caselli M; Trevisani L; Tursi A; Sartori S; Ruina M; Luzzi I; Gaudenzi P; Alvisi V; Gasbarrini G
Eur J Gastroenterol Hepatol; 1997 Jan; 9(1):45-8. PubMed ID: 9031898
[TBL] [Abstract][Full Text] [Related]
18. Short duration therapy for Helicobacter pylori in Western Australia: the impact of metronidazole resistance.
Forbes GM; Collins BJ; McCullough CA; Coombs GW; Robins PD
Aust N Z J Med; 1998 Feb; 28(1):13-7. PubMed ID: 9544380
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients.
Pilotto A; Franceschi M; Leandro G; Bozzola L; Fortunato A; Rassu M; Meli S; Soffiati G; Scagnelli M; Di Mario F; Valerio G
J Gastroenterol Hepatol; 1999 May; 14(5):468-75. PubMed ID: 10355512
[TBL] [Abstract][Full Text] [Related]
20. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
